Ihrig, Andreas http://orcid.org/0000-0002-8497-9193
Pernt, Pascal Marino
Zschäbitz, Stefanie
Huber, Johannes http://orcid.org/0000-0001-7243-8958
Friederich, Hans-Christoph http://orcid.org/0000-0003-4344-8959
Bugaj, Till J. http://orcid.org/0000-0001-8287-2635
Maatouk, Imad http://orcid.org/0000-0002-8030-1182
Clinical trials referenced in this document:
Documents that mention this clinical trial
Neurocognitive effects of androgen deprivation therapy and new hormonal agents in a sample of patients with metastatic prostate cancer
https://doi.org/10.1007/s11255-023-03712-z
Funding for this research was provided by:
Universitätsklinikum Heidelberg
Article History
Received: 9 May 2023
Accepted: 12 July 2023
First Online: 19 July 2023
Declarations
:
: The authors have no relevant financial or nonfinancial interests to disclose.
: All patients provided informed consent before study entry.
: Approval for the study was obtained from the Ethics Committee of the Medical Faculty of the University of Heidelberg (S-178/2019).